晨暉生技 (1271.TW) 2025Q4 financial report shows net profit of 57.43M TWD, with a YoY growth rate of 21.84%, clearly higher than last year, showing strong profit momentum and good management efficiency. It is recommended to monitor revenue, cash flow, and industry trends, and use Growin AI Value Analysis to seize growth opportunities. Overall, the company has shown a solid growth curve and future performance is worth watching.